Lisa Morden Archives - CDR – Chain Drug Review

Kimberly-Clark’s sustainability programs recognized

November 5, 2018 by Chain Drug Review 2018 Responsible Business Award for Climate Action from Ethical Corporation, 9th annual Ethical Corporation Responsible Business Awards, Ed Long, global Energy & Climate program, Kimberly-Clark Corp., Lisa Morden Leading Headlines, Supplier News

DALLAS — Kimberly-Clark Corp. has been recognized with two prominent awards for its efforts to improve energy efficiency and reduce its carbon footprint. The company received the 2018 Responsible Business Award for Climate Action from Ethical Corporation, and earned its sixth consecutive SmartWay Excellence Award from the U.S. Environmental Protection Agency for leadership in freight supply

Kimberly-Clark reports progress to sustainability 2022 goals

June 27, 2018 by Chain Drug Review Kimberly-Clark, Kimberly-Clark's 2017 Global Sustainability Report, Lisa Morden, Thomas Falk Supplier News

DALLAS — Kimberly-Clark Corp. has reported its progress toward achieving its Sustainability 2022 strategy to create social, environmental and business value. “We continue to make strides in our efforts to create positive social and environmental change,” said Thomas Falk, Kimberly-Clark’s chairman and chief executive officer. “That’s why we are committed to an ambitious set of sustainability goals that will